Oct. 3, 2024
The American College of Radiology® (ACR®) presented two code families for valuation at the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) meeting Sept. 25-28, in Washington, DC. The outcome of both families will be discussed in the 2026 Medicare Physician Fee Schedule.

CT cerebral perfusion and CTA head and neck was presented in collaboration with the American Society of Neuroradiology. Prostate biopsy was a multispecialty effort with the American Urological Association, the Society of Interventional Radiology, and the Outpatient Endovascular and Interventional Society.

The practice expense and physician work for both families was presented to the RUC Panel by ACR RUC Advisors Andrew Moriarity, MD, and Michael Booker, MD, MBA, along with guest presenter Cindy Yuan, MD, PhD, RUC Advisor for the Radiology Society of North America. Gregory Nicola, MD, FACR, and Lauren Nicola, MD, FACR, represented radiology on the RUC panel. Additionally, the College hosted Robert Bour, MD, Benjamin Northrup, MD, Alan Matsumoto, MD, MA, FACR, Chair of the ACR Board of Chancellors, and Jennifer Padwal, MD, MAS our most recent Moorefield Fellow. All four were first-time observers of the RUC process.

ACR is now working on the surveys for the January meeting. The College anticipates surveys will be launched later this month. Due to the short survey cycle, ACR urges members to prioritize any received RUC surveys.

For more information or if you have questions, contact Stephanie Le, ACR Director, Economic Policy.

Related ACR News

  • ACR Attends 2025 RUC Meetings

    ACR participated in the American Medical Association/Specialty Society RVS Update Committee meeting where they heard updates on the AMA Physician Practice Information Survey.

    Read more
  • NCI Releases FY 2027 Budget Proposal

    Anthony Letai, MD, PhD, became NCI Director Sept. 29, leading with a $7.2B budget and proposing $11.5B for FY 2027 to boost cancer research.

    Read more
  • Lead the Future of Alzheimer's Imaging

    Join ALZ-NET Imaging Network to access AI tools, boost Alzheimer’s imaging, and contribute data to shape FDA safety and clinical guidelines.

    Read more